Recurrent Primitive Neuroectodermal Tumor: Clinical Trials

3 trials for Recurrent Primitive Neuroectodermal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Unknown 1, Withdrawn 1
Phase 21Unknown 1

Follow Recurrent Primitive Neuroectodermal Tumor: new trials by email Literature Review of Recurrent Primitive Neuroectodermal Tumor trials Research Report on Recurrent Primitive Neuroectodermal Tumor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Etoposide, Fludarabine Phosphate, Hematopoietic Cell Transplantation - Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor
Phase 1WithdrawnM.D. Anderson Cancer Center2021-01-142024-10-26
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
Laboratory Biomarker Analysis, Sargramostim, Wild-type Reovirus - Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor
Phase 1CompletedMayo Clinic62015-06-212023-04-24
Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors
Carboplatin, Mannitol, Melphalan - Central Nervous System Embryonal Neoplasm, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered
Phase 1 / Phase 2UnknownOHSU Knight Cancer Institute172009-07-092021-10-26

Narrower conditions

Medulloblastoma (3)  ·  Neuroectodermal Tumors, Primitive (3)  ·  Brain Neoplasms (2)  ·  Glioma (2)  ·  Rhabdoid Tumor (2)  ·  Astrocytoma (1)  ·  Choroid Plexus Carcinoma (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Ependymoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Oligodendroglioma (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Complex and Mixed (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Brain Stem Neoplasms (1)

Interventions

Melphalan (2)  ·  Antilymphocyte Serum (1)  ·  Carboplatin (1)  ·  Colony-Stimulating Factors (1)  ·  Etoposide (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Mannitol (1)  ·  Mycophenolic Acid (1)  ·  Stem Cell Transplantation (1)  ·  Tacrolimus (1)  ·  Thiotepa (1)  ·  fludarabine phosphate (1)  ·  reolysin (1)  ·  sargramostim (1)  ·  sodium thiosulfate (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (2)

Top investigators

Edward A Neuwelt (1)  ·  Kris M Mahadeo, MD (1)  ·  Richard Bram (1)

NIH funding

P30CA015083 (1), R01NS044687 (1)